Causes, Consequences, Challenges and Opportunities of Tumor Angiogenesis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 233
Special Issue Editors
Interests: PET/CT; molecular imaging; radiopharmaceuticals; prostate cancer; PET/MRI
Special Issues, Collections and Topics in MDPI journals
Interests: diagnostic imaging; molecular imaging; nuclear medicine; theragnostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neoangiogenesis is essential for the growth of tumors, mainly in the case of solid and undifferentiated cancers. Magnetic resonance imaging (MRI) with contrast enhancement (ce) and new radiopharmaceutical agents for PET imaging can be useful to detect and also to monitor this pathophysiological process. This Special Issue aims to:
- Define the role of MRI with ce and the role of other imaging technologies in evaluating the neoangiogenesis.
- Assess the advantages of new radiopharmaceutical agents for monitoring the evaluation of response to new targeted therapies in tumors.
Dr. Laura Evangelista
Prof. Dr. Luigi Mansi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neoangiogenesis
- PET
- MRI
- radiopharmaceutical agents
- hypoxia
